Rankings
▼
Calendar
CLDX (Celldex Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$2M
Net Income (TTM)
-$259M
EPS (TTM)
-$3.90
Free Cash Flow (TTM)
-$213M
Gross Margin
100.0%
Op. Margin
-19160.0%
Net Margin
-17253.3%
FCF Margin
-14224.7%
P/S Ratio (TTM)
1405.2x
P/E Ratio (TTM)
—
YoY Rev Growth
-78.6%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$967K
-$26M
-$32M
Q2 23
$268K
-$26M
-$33M
Q3 23
$2M
$750K
-$41M
Q4 23
$4M
-$26M
-$48M
Q1 24
$156K
-$619K
-$41M
Q2 24
$2M
$2M
-$46M
Q3 24
$3M
$3M
-$52M
Q4 24
$1M
$356K
-$56M
Q1 25
$695K
$695K
-$63M
Q2 25
$730K
$730K
-$64M
Q3 25
$0
$0
-$74M
Q4 25
$75K
$75K
-$87M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
669.1x
—
Q2 23
647.6x
—
Q3 23
482.9x
—
Q4 23
306.2x
—
Q1 24
347.1x
—
Q2 24
253.9x
—
Q3 24
211.3x
—
Q4 24
300.3x
—
Q1 25
278.8x
—
Q2 25
364.0x
—
Q3 25
810.7x
—
Q4 25
1405.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$29M
-$29M
Q2 23
-$27M
-$28M
Q3 23
-$19M
-$19M
Q4 23
-$33M
-$33M
Q1 24
-$41M
-$41M
Q2 24
-$29M
-$30M
Q3 24
-$55M
-$55M
Q4 24
-$32M
-$33M
Q1 25
-$54M
-$55M
Q2 25
-$44M
-$45M
Q3 25
-$49M
-$49M
Q4 25
-$64M
-$65M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$585K
Q2 23
$410K
Q3 23
$157K
Q4 23
$666K
Q1 24
$344K
Q2 24
$274K
Q3 24
$618K
Q4 24
$756K
Q1 25
$265K
Q2 25
$728K
Q3 25
$440K
Q4 25
$993K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+455.7%
+42.7%
Q2 23
+64.4%
-8.4%
Q3 23
+272.7%
+52.1%
Q4 23
+156.1%
+75.5%
Q1 24
-83.9%
+21.9%
Q2 24
+832.1%
+45.8%
Q3 24
+110.3%
+29.4%
Q4 24
-71.6%
+10.5%
Q1 25
+345.5%
+55.6%
Q2 25
-70.8%
+32.3%
Q3 25
-100.0%
+33.1%
Q4 25
-93.6%
+52.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$4M
448.8%
Q2 23
$5M
1946.6%
Q3 23
$7M
469.4%
Q4 23
$7M
174.6%
Q1 24
$7M
4616.7%
Q2 24
$8M
305.8%
Q3 24
$10M
301.5%
Q4 24
$10M
832.3%
Q1 25
$9M
1340.4%
Q2 25
$9M
1259.0%
Q3 25
$9M
—
Q4 25
$9M
11878.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$27M
$7M
Q2 23
$26M
$7M
Q3 23
$35M
$8M
Q4 23
$30M
$9M
Q1 24
$31M
$9M
Q2 24
$39M
$9M
Q3 24
$3K
$10M
Q4 24
$46M
$10M
Q1 25
$53M
$11M
Q2 25
$54M
$10M
Q3 25
$63M
$11M
Q4 25
$75M
$12M
marketcaparena.com
Revenue Segments
Grant
Service
Quarter
Grant
Service
Q1 23
$967K
—
Q2 23
$252K
$16K
Q3 23
$2M
$2K
Q1 24
$154K
$2K
Q2 24
$2M
$2K
Q3 24
$3M
$3K
Q1 25
$645K
$50K
Q2 25
$723K
$7K
Q3 25
$1M
$57K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$54M
$224M
$278M
Q2 23
$28M
$224M
$253M
Q3 23
$21M
$214M
$235M
Q4 23
$35M
$387M
$422M
Q1 24
$115M
$709M
$824M
Q2 24
$43M
$760M
$802M
Q3 24
$36M
$720M
$756M
Q4 24
$28M
$697M
$725M
Q1 25
$17M
$656M
$673M
Q2 25
$23M
$607M
$630M
Q3 25
$36M
$547M
$583M
Q4 25
$29M
$490M
$519M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
47M
+0.2%
Q2 23
47M
+0.1%
Q3 23
47M
+0.0%
Q4 23
52M
+10.1%
Q1 24
59M
+13.2%
Q2 24
66M
+12.1%
Q3 24
66M
+0.4%
Q4 24
66M
+0.1%
Q1 25
66M
+0.0%
Q2 25
66M
+0.0%
Q3 25
66M
+0.0%
Q4 25
67M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$22K
161
FY 15
$28K
199
FY 16
$32K
210
FY 17
$65K
197
FY 18
$70K
137
FY 19
$27K
130
FY 20
$59K
125
FY 21
$35K
134
FY 22
$16K
148
FY 23
$43K
160
FY 24
$38K
186
FY 25
$8
200K
marketcaparena.com